No connection

Search Results

MRM vs QVCGA

MRM
MEDIROM Healthcare Technologies Inc.
BEARISH
Price
$1.11
Market Cap
$8.8M
Sector
Consumer Cyclical
AI Confidence
90%
QVCGA
QVC Group Inc.
BEARISH
Price
$0.64
Market Cap
$8.0M
Sector
Consumer Cyclical
AI Confidence
95%

Valuation

P/E Ratio
MRM
3.0
QVCGA
--
Forward P/E
MRM
--
QVCGA
--
P/B Ratio
MRM
5.73
QVCGA
-0.0
P/S Ratio
MRM
0.0
QVCGA
0.0
EV/EBITDA
MRM
27.83
QVCGA
8.44

Profitability

Gross Margin
MRM
25.05%
QVCGA
34.3%
Operating Margin
MRM
-25.84%
QVCGA
0.3%
Profit Margin
MRM
0.5%
QVCGA
-26.42%
ROE
MRM
53.19%
QVCGA
--
ROA
MRM
-1.78%
QVCGA
2.25%

Growth

Revenue Growth
MRM
-6.7%
QVCGA
-9.1%
Earnings Growth
MRM
--
QVCGA
--

Financial Health

Debt/Equity
MRM
7.86
QVCGA
--
Current Ratio
MRM
0.24
QVCGA
0.63
Quick Ratio
MRM
0.14
QVCGA
0.45

Dividends

Dividend Yield
MRM
--
QVCGA
--
Payout Ratio
MRM
0.0%
QVCGA
0.0%

AI Verdict

MRM BEARISH

MRM presents a high-risk profile characterized by a Piotroski F-Score of 4/9 (Stable) but severe underlying liquidity distress. While the stock trades below its Graham Number ($1.27) and Intrinsic Value ($2.59), these valuation metrics are overshadowed by a catastrophic Current Ratio of 0.24 and an extreme Debt/Equity ratio of 7.86. The company is experiencing declining revenue growth (-6.70%) and deep operating losses (-25.84% margin), suggesting that the nominal net profit is likely driven by non-operating items rather than core business health.

Strengths
Current price is below the Graham Number ($1.27)
Very low P/E ratio of 3.00
Positive net profit margin (0.50%)
Risks
Severe liquidity crisis with a Current Ratio of 0.24
Extreme leverage with Debt/Equity at 7.86
Negative operating margin of -25.84% indicating core business inefficiency
QVCGA BEARISH

QVCGA exhibits extreme financial distress, anchored by a weak Piotroski F-Score of 2/9 and a catastrophic price collapse of -99.9% over five years. The company is facing a severe liquidity crisis with a current ratio of 0.63 and a quick ratio of 0.45, indicating an inability to meet short-term obligations. Negative profit margins (-26.42%) combined with declining revenue growth (-9.10% YoY) suggest a failing business model. The absence of a Graham Number and a Price/Book of -0.00 point toward negative shareholder equity and imminent insolvency risk.

Strengths
Positive gross margin of 34.30%
Positive ROA of 2.25% (though marginal)
Operating margin remains slightly positive at 0.30%
Risks
Severe liquidity crisis (Current Ratio 0.63)
Negative shareholder equity (Price/Book -0.00)
Catastrophic price trend (-90.9% 1Y change)

Compare Another Pair

MRM vs QVCGA: Head-to-Head Comparison

This page compares MEDIROM Healthcare Technologies Inc. (MRM) and QVC Group Inc. (QVCGA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile